Attenuation of the Stimulant Response to Ethanol is Associated with Enhanced Ataxia for a GABAA, but not a GABAB, Receptor Agonist
Open Access
- 22 December 2008
- journal article
- research article
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 33 (1) , 108-120
Abstract
Background: The γ‐aminobutyric acid (GABA) system is implicated in the neurobiological actions of ethanol, and pharmacological agents that increase the activity of this system have been proposed as potential treatments for alcohol use disorders. As ethanol has its own GABA mimetic properties, it is critical to determine the mechanism by which GABAergic drugs may reduce the response to ethanol (i.e., via an inhibition or an accentuation of the neurobiological effects of ethanol).Methods: In this study, we examined the ability of 3 different types of GABAergic compounds, the GABA reuptake inhibitor NO‐711, the GABAAreceptor agonist muscimol, and the GABABreceptor agonist baclofen, to attenuate the locomotor stimulant response to ethanol in FAST mice, which were selectively bred for extreme sensitivity to ethanol‐induced locomotor stimulation. To determine whether these compounds produced a specific reduction in stimulation, their effects on ethanol‐induced motor incoordination were also examined.Results: NO‐711, muscimol, and baclofen were all found to potently attenuate the locomotor stimulant response to ethanol in FAST mice. However, both NO‐711 and muscimol markedly increased ethanol‐induced ataxia, whereas baclofen did not accentuate this response.Conclusions: These results suggest that pharmacological agents that increase extracellular concentrations of GABA and GABAAreceptor activity may attenuate the stimulant effects of ethanol by accentuating its intoxicating and sedative properties. However, selective activation of the GABABreceptor appears to produce a specific attenuation of ethanol‐induced stimulation, suggesting that GABABreceptor agonists may hold greater promise as potential pharmacotherapies for alcohol use disorders.Keywords
This publication has 92 references indexed in Scilit:
- Tackling Alcoholism With DrugsScience, 2008
- Studies of ethanol actions on recombinant δ-containing γ-aminobutyric acid type A receptors yield contradictory resultsAlcohol, 2007
- GABAA receptor subtypes: the “one glass of wine” receptorsAlcohol, 2007
- Matching clients' treatment goals with treatment oriented towards abstinence, moderation or harm reductionAddiction, 2006
- Sensitivity to Ketamine, Alone or in Combination With Ethanol, Is Altered in Mice Selectively Bred for Sensitivity to Ethanol's Locomotor EffectsAlcohol, Clinical and Experimental Research, 2003
- Baclofen antagonizes nicotine‐, cocaine‐, and morphine‐induced dopamine release in the nucleus accumbens of ratSynapse, 2003
- Sensitivity to the locomotor stimulant effects of ethanol and allopregnanolone is influenced by common genes.Behavioral Neuroscience, 2002
- Locomotor activity responses to ethanol, other alcohols and GABA-A acting compounds in forward- and reverse-selected FAST and SLOW mouse lines.Behavioral Neuroscience, 2002
- Ability of Baclofen in Reducing Alcohol Craving and Intake: II—Preliminary Clinical EvidenceAlcohol, Clinical and Experimental Research, 2000
- Chronic tolerance and sensitization to alcohol in sons of alcoholics: II. Replication and reanalysis.Experimental and Clinical Psychopharmacology, 1999